Skip to main content

Research Repository

Advanced Search

Evaluation of recombinant factor C assay for the detection of divergent lipopolysaccharide structural species and comparison with Limulus amebocyte lysate-based assays and a human monocyte activity assay

Sattar, Anas A.; Jackson, Simon K.; Abate, Wondwossen; Liu, Jian; Conway, Myra E.

Evaluation of recombinant factor C assay for the detection of divergent lipopolysaccharide structural species and comparison with Limulus amebocyte lysate-based assays and a human monocyte activity assay Thumbnail


Authors

Anas A. Sattar

Simon K. Jackson

Wondwossen Abate

Jian Liu

Myra Conway Myra.Conway@uwe.ac.uk
Occasional Associate Lecturer - CHSS - DAS



Abstract

© 2017 The Authors. Purpose. The Limulus amebocytelysate (LAL) assay is widely used for the screening of lipopolysaccharide (LPS) in parenteral pharmaceuticals. However, correlation of LPS in Gram-negative bacterial infections by LAL assay has been problematic, partly due to the variable reactivity of different LPS structures. Recombinant factor C (rFC) has allowed the development of a new simple, specific and sensitive LPS detection system (PyroGene). In this work, the potential of the new assay for detecting various LPS structures has been investigated and compared with two LAL-based assays and a human monocyte activity assay. Methodology. The activity of the various LPS structures has been investigated by PyroGene and two LAL-based assays and a human monocyte activity assay. Results. The rFC assay detected most LPS structures in picogram quantities and the potency of E. coli, B. cepacia, Salmonella smooth and Salmonella R345 LPS was no different when measured with PyroGene or LAL assays. However, the reactivity of K. pneumoniae, S. marcescens, B. pertussis and P. aeruginosa LPS differed significantly between these assays. Importantly, pairwise correlation analysis revealed that only the PyroGene assay produced a significant positive correlation with the release of IL-6 from a monocytic cell line. Conclusion. We conclude that the rFC-based assay is a good replacement for conventional LAL assays and as it correlates significantly with IL-6 produced by a human monocyte cell line it could potentially be more useful for detecting LPS in a clinical setting.

Citation

Jackson, S. K., Sattar, A. A., Abate, W., Liu, J., & Conway, M. E. (2017). Evaluation of recombinant factor C assay for the detection of divergent lipopolysaccharide structural species and comparison with Limulus amebocyte lysate-based assays and a human monocyte activity assay. Journal of Medical Microbiology, 66(7), 888-897. https://doi.org/10.1099/jmm.0.000510

Journal Article Type Article
Acceptance Date May 8, 2017
Online Publication Date Jul 10, 2017
Publication Date Jul 1, 2017
Deposit Date Jul 13, 2017
Publicly Available Date Jul 10, 2018
Journal Journal of Medical Microbiology
Print ISSN 0022-2615
Publisher Microbiology Society
Peer Reviewed Peer Reviewed
Volume 66
Issue 7
Pages 888-897
DOI https://doi.org/10.1099/jmm.0.000510
Keywords lipopolysaccharide, recombinant factor C, LAL, cytokine
Public URL https://uwe-repository.worktribe.com/output/884638
Publisher URL http://dx.doi.org/10.1099/jmm.0.000510

Files






You might also like



Downloadable Citations